08.07.20FDA Agrees to Review Aducanumab--First Potential Treatment for Alzheimer Disease in Decades
07.31.20Alzheimer Disease Risk May Be Measurable in Adolescence and Early Adulthood
07.29.20Survey Shows Significant Burden of Visual Hallucinations and Paranoid Delusions for People With Dementia
07.29.20Flu and Pneumonia Vaccination Correlates With Reduced Incidence of Alzheimer Disease
07.28.20Plasmapheresis With Albumin Delays Cognitive and Functional Declines in Clinical Trial for Alzheimer Disease
07.21.20FDA Accepts Supplemental New Drug Application for Pimavanserin for Dementia-Related Psychosis Symptoms
Neurologists need to have a palliative care skill set.
Jessica M. Baker, MD
Dementia Insights: Language and Dementia
Who can take us seriously when we are so far from who we once were?; Everything she did and loved, everything she was, required language. -Lisa Genova, Still Alice.
Farhat Husain, MD; Divya Singhal, MD; and Sergio Ramirez Salazar, MD
Symptoms of Lewy Body Dementia Induced by Herpes Zoster Encephalitis
Ryan Verity, MD; Andrew Kirk, MD, FRCPC; and Gary Hunter, MD, FRCPC, CSCN(EEG)
07.17.20Dopamine Improves Cognitive Function in Mild-to-Moderate Alzheimer Disease
07.15.20Phase 3 Clinical Trial for Antiamyloid Beta Treatment of Preclinical Alzheimer Disease Initiated
07.08.20Aducanumab for Alzheimer Disease Treatment Submitted to FDA for Approval
06.24.20Higher Rates of Alzheimer Disease Not Related to Longer Life in Women
06.24.20Phase 2 Clinical Trial for Stem-Cell Treatment of Alzheimer Disease Planned
06.18.20New Indication for Pimavanserin—Dementia Related Psychosis—Submitted to the FDA
06.17.20Phase 2 Trial of Tauroursodeoxycholic Acid for Alzheimer Disease Completes Enrollment
Teleneurology Billing and Coding
Perspectives on coding evaluation & management during the COVID-19 pandemic.
Brad Klein, MD, MBA, FAAN, FAHS, FAANEM, and Raissa Villanueva MD, MPH, FAAN
Teleneurology for Cognitive Care
Modified workflow and adapted examinations for teleneurology can aid earlier diagnosis and treatment for most cognitive disorders.
Chen Zhao, MD; Claire Flaherty, PhD; Paul J. Eslinger, PhD; and Krishnankutty Sathian, MBBS, PhD